• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

July 21, 2022

Specific Form of Age-Related Macular Degeneration Linked to Heart Disease and Stroke

Author(s):

Lindsey Mulrooney

Findings suggest potential screening and disease detection opportunities.

Patients with a specific form of age-related macular degeneration (AMD) characterized by subretinal drusenoid deposits (SDD) are at a significant risk for cardiovascular disease and stroke, according to research published in the July issue of Retina.

The study, conducted by researchers from New York Eye and Ear Infirmary of Mount Sinai, is the first to demonstrate an association between the disorders.

“For the last 3 decades, researchers have suggested an association between AMD and cardiovascular disease, but there has been no conclusive data on this until now.” lead author R. Theodore Smith, MD, PhD, Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai, said in a press release. “Our retinal team answered this important question by focusing on 2 different varieties of AMD that can be seen with advanced retinal imaging. We discovered that only 1 form of AMD, that with subretinal drusenoid deposits, is tightly connected to high-risk vascular diseases, and the other form, known as drusen, is not,”

AMD is known to be the leading cause of visual impairment and blindness among individuals over 65 years of age in the United States. AMD is the result of damage to the central area of the retina, the macula, which is responsible for reading and vision.

Drusen is a major form of early AMD, characterized by small yellow cholesterol deposits forming in a layer under the retina. These deposits can deprive the retina of blood and oxygen, leading to vision loss.

The other major form of early AMD involves the presence of SDD and is lesser known. High-tech retinal imaging is required to detect SDD. Similar to the deposits found in patients with drusen, SDD are made of fatty lipids and other materials. However, they form in a different layer beneath the light sensitive retina cells, also causing vision loss. Currently, there is no known treatment available for SDD.

Researchers at Mount Sinai examined patients using optical coherence tomography (OCT), an advanced imaging system that provides high-resolution cross-sectional scans of the retina. Patients were also asked to answer questionnaires about their health history, including heart disease and stroke.

There were 126 patients participating in the study, including 64 patients with drusen and 62 patients with SDD. Of the 51 patients who reported having cardiovascular disease or a past stroke, 66% had SDD. Only 19% of the 75 patients who did not have known heart disease or stroke had SDD.

Researchers found that patients with cardiovascular disease or stroke were 3 times more likely to have SDD than participants without.

"If ophthalmologists diagnose or treat someone with the specific subretinal drusenoid deposits form of AMD, but who otherwise seems well, that patient may have significant undetected heart disease or possibly carotid artery stenosis that could result in a stroke,” Smith said in the press release. “We foresee that in the future, as an improved standard of care, such patients will be considered for early referral to a cardiologist for evaluation and possibly treatment.”

The researchers suggest that the underlying heart and vascular disease likely compromises blood circulation in the eye, which may lead to the SDDs beneath the retina.

“We believe poor ocular circulation that causes SDDs is a manifestation of underlying vascular disease. This has important public health implications and can facilitate population screening and disease detection with major impact,” author Jagat Narula, MD, PhD, Associate Dean of Global Affairs and Professor of Medicine (Cardiology), and Radiology, at the Icahn School of Medicine at Mount Sinai, explained in the press release. “Seen in an eye clinic, such patients should be prompted to see a cardiologist. On the other hand, if clinically substantiated in prospective studies, SDDs could emerge as a risk marker for underlying vascular disease in asymptomatic patients in primary care or a cardiology clinic. The temporal relationship between SDDs and macrovascular disease will also need to be established in prospective studies which are currently in progress.”

The researchers had also collected patient blood samples as part of the study. Results showed that genetic risk factors may also play a role in SDD cases in addition to vascular causes. The ARMS2 gene was found to act independently of vascular disease to cause SDD in some patients.

“This study further demonstrates that AMD is not a single condition or an isolated disease but is often a signal of systemic malfunction which could benefit from targeted medical evaluation in addition to localized eye care,” Richard B. Rosen, MD, Chief of the Retina Service for the Mount Sinai Health System, said in the press release. “It helps bring us one step closer to unraveling the mystery of this horrible condition which robs so many patients of the pleasure of good vision during their later years.”

Reference

Blinding eye disease is strongly associated with heart disease and stroke. Science Daily website. https://www.sciencedaily.com/releases/2022/07/220712102746.htm. Published July 12, 2022. Accessed July 13, 2022.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Pharmacist and doctor -- Image credit: ake1150 | stock.adobe.com
Pharmacist and patient -- Image credit: Zamrznuti tonovi | stock.adobe.com
Related Content
Advertisement
After the Approval: Assessing RSV Vaccine Safety in Older Adults and Pregnant Patients
August 14th 2025

After the Approval: Assessing RSV Vaccine Safety in Older Adults and Pregnant Patients

Monica Holmberg, PharmD, BCPS
A New Joint Scientific Statement and What to Watch for at the European Society of Cardiology Congress 2025
August 14th 2025

A New Joint Scientific Statement and What to Watch for at the European Society of Cardiology Congress 2025

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP
Patient Perceptions Support Co-Management of Chronic Kidney Disease
August 14th 2025

Patient Perceptions Support Co-Management of Chronic Kidney Disease

Helen Pervanas, PharmD
A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025
August 14th 2025

A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP
Woman doctor nutritionist hands in white shirt with omega 3, vitamin D capsules with green vegan food. The doctor prescribes a prescription for medicines and vitamins at clinic | Image Credit: Galina Zhigalova | stock.adobe.com
August 14th 2025

Mechanistic Rationale and Safety Considerations for the Combined Supplementation of Vitamins D and K

Danielle Valletti, Assistant Editor
Prague,Czech republic-June 17 2024: Jardiance box of medication with Empagliflozin active substance by Boehringer Ingelheim,used for treatment of Type 2 diabetes,Heart failure,Hyperglycemia - Image credit: Semi | stock.adobe.com
August 14th 2025

A Few Key Points Can Guide SGLT2 Inhibitor Management

Jeannette Y. Wick, MBA, RPh, FASCP
Related Content
Advertisement
After the Approval: Assessing RSV Vaccine Safety in Older Adults and Pregnant Patients
August 14th 2025

After the Approval: Assessing RSV Vaccine Safety in Older Adults and Pregnant Patients

Monica Holmberg, PharmD, BCPS
A New Joint Scientific Statement and What to Watch for at the European Society of Cardiology Congress 2025
August 14th 2025

A New Joint Scientific Statement and What to Watch for at the European Society of Cardiology Congress 2025

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP
Patient Perceptions Support Co-Management of Chronic Kidney Disease
August 14th 2025

Patient Perceptions Support Co-Management of Chronic Kidney Disease

Helen Pervanas, PharmD
A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025
August 14th 2025

A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP
Woman doctor nutritionist hands in white shirt with omega 3, vitamin D capsules with green vegan food. The doctor prescribes a prescription for medicines and vitamins at clinic | Image Credit: Galina Zhigalova | stock.adobe.com
August 14th 2025

Mechanistic Rationale and Safety Considerations for the Combined Supplementation of Vitamins D and K

Danielle Valletti, Assistant Editor
Prague,Czech republic-June 17 2024: Jardiance box of medication with Empagliflozin active substance by Boehringer Ingelheim,used for treatment of Type 2 diabetes,Heart failure,Hyperglycemia - Image credit: Semi | stock.adobe.com
August 14th 2025

A Few Key Points Can Guide SGLT2 Inhibitor Management

Jeannette Y. Wick, MBA, RPh, FASCP
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.